1989
DOI: 10.1016/0163-7258(89)90074-0
|View full text |Cite
|
Sign up to set email alerts
|

Lipid metabolism and retinoid therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

1990
1990
1999
1999

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(12 citation statements)
references
References 37 publications
0
12
0
Order By: Relevance
“…The triacylglycerol concentration in serum was not significantly increased in these patients (tab. 2), possibly because Roaccutane™ dose was relatively low (21), or because we missed the increase due to the design of the experiment.…”
Section: Discussionmentioning
confidence: 91%
“…The triacylglycerol concentration in serum was not significantly increased in these patients (tab. 2), possibly because Roaccutane™ dose was relatively low (21), or because we missed the increase due to the design of the experiment.…”
Section: Discussionmentioning
confidence: 91%
“…This is similar to the metabolic abnormality seen in familial combined hyperlipidaemia. In addition, there is an increased degradation of LDL-rich cholesterol (Marsden 1989).…”
Section: Effects On Lipid Metabolismmentioning
confidence: 99%
“…In humans, vitamin A derivative, isotretinoin (13‐ cis ‐RA) is shown to be effective in the treatment of dermatological diseases, but a side‐effect of treatment with retinoids is hyperlipidemia. In general, very low density lipoprotein (VLDL) triglyceride levels and cholesterol levels, predominantly contained in low density lipoproteins (LDL), as well as apoB‐100 levels, are increased after long‐term isotretinoin treatment [8–11]. Little or no changes in HDL‐cholesterol, apoA‐I and apoA‐II are found [8–11].…”
Section: Effect Of Treatment With Placebo or Isotretinoin On Concentrmentioning
confidence: 99%